Tag: renal biomarkers market report

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Biomarkers Market Grown from 2024 to 2025?

The market size for biomarkers has experienced rapid expansion in recent years. Competition will heat up, with a predicted rise from $68.77 billion in 2024 to $78.14 billion in 2025, boasting a compound annual growth rate (CAGR) of 13.6%. The significant growth observed in the historic period can be linked to the progress made in genomics and proteomics technologies, the escalating cases of chronic diseases, the growing focus on personalized medicine, the increased need for companion diagnostics, and the widening applicability in drug development.

What Growth Rate Is Anticipated for the Biomarkers Market in the Coming Years?

The future holds promising expansion for the biomarkers market, with a projected surge to $135.14 billion by 2029. This growth represents a compound annual growth rate (CAGR) of 14.7%. The rise is due to an increasing emphasis on early disease discovery and prevention, broadening of the use of biomarkers in the fields of oncology and immunotherapy, growing investments in precision medicine, emergence of liquid biopsy as a non-invasive method for biomarker detection, and the favoured use of biomarkers in drug discovery and creation. The forecast period will also see trends such as the creation of multi-biomarker panels, the emergence of exosome-based biomarkers, adoption of point-of-care biomarker testing, incorporation of real-world data into biomarker research, and the search for microbiome-based biomarkers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

Who Are the Leading Companies in the Biomarkers Market?

Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

What Are the Key Drivers of the Biomarkers Market?

The rise in cardiac illnesses is predicted to boost the growth of the biomarkers market during the forecast period. There has been a tremendous surge in the application of biomarkers for patients suffering from heart diseases in recent years. At present, natriuretic peptides dominate as the most frequently used biomarker, aiding in the diagnosis of heart failure patients. Other biomarkers like circulating biomarkers loaded with high sensitivity C-reactive protein are also employed for heart failure diagnosis. Heart diseases are a prominent cause of mortality among numerous racial and ethnic groups in the United States, thus increasing the demand for biomarkers. For instance, as per a report by the American College of Cardiology, a non-profit medical association from the United States, published in August 2022, it was projected that all four cardiovascular risk factors would undergo an increase from 2025 to 2060 in the region. Diabetes is predicted to show the highest rise in percentage, increasing by 39.3% to touch 55 million people. It is followed by dyslipidemia, which is expected to increase by 27.6% reaching 126 million people, hypertension is expected to surge by 25.1% reaching 162 million, and obesity with an increase of 18.3% will affect 126 million people. The study also noticed significant projected enhancements in cardiovascular disease rates like strokes, projected to grow by 33.8% affecting 15 million people, and heart failure anticipating an increase of 33.4% to affect 13 million people. This is followed by ischemic heart disease (30.7% to reach 29 million) and heart attacks (16.9% to touch 16 million). The escalation in heart diseases and related mortalities is expected to stimulate the growth of the biomarkers market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

What Are the Key Market Segments in the Biomarkers Industry?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

What Are the Latest Trends in the Biomarkers Market?

Leading companies in the biomarker market are channeling their efforts into the development of innovative solutions, such as fresh biological markers, to spur innovation through cooperative research, technological fusion, and solid clinical validation. A fresh biological marker represents a freshly discovered indicator that mirrors biological activities and aids in detecting or monitoring diseases. It could be a molecule, gene, or cell feature which may have potential consequences for personalized medicine. For example, Genialis, a computational precision medicine corporation based in the US, inaugurated a first-in-class biomarker in September 2024. This first-in-class biomarker boosts the predictive accuracy for patient responses to KRAS inhibitors, facilitating personalized treatment strategies, and enhancing clinical results. Its comprehensive application across various types of cancer promotes efficient pharmaceutical development and optimizes patient selection for targeted treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Are the Key Regional Markets in the Biomarkers Industry?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

This Report Delivers Insight On:

1. How big is the biomarkers market, and how is it changing globally?

2. Who are the major companies in the biomarkers market, and how are they performing?

3. What are the key opportunities and risks in the biomarkers market right now?

4. Which products or customer segments are growing the most in the biomarkers market?

5. What factors are helping or slowing down the growth of the biomarkers market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the biomarkers industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Biomarkers Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The size of the biomarkers market has seen a fast-paced expansion lately. The market which was valued at $68.77 billion in 2024, is predicted to advance to $78.14 billion by 2025, with a compound annual growth rate (CAGR) of 13.6%. This swift growth in the historic period is a result of advancements in the fields of genomics and proteomics, a surge in chronic disease prevalence, heightened focus on individualized medicine, increased need for companion diagnostics, and the broadening of applications in pharmaceutical development.

In the ensuing years, a fast expansion is anticipated in the biomarkers market, with its value projected to escalate to $135.14 billion in 2029, experiencing a compound annual growth rate (CAGR) of 14.7%. Factors such as the emphasis on early disease detection and prevention, the inclining utility of biomarkers in oncology and immunotherapy, growth in investment in precision medicine initiatives, the emergence of liquid biopsy as a non-aggressive method for biomarker detection, and the increased usage of biomarkers in drug discovery and development are significantly contributing to this growth for the forecasted period. Key trends anticipated during this timeframe include the progression of multi-biomarker panels, the rise of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the integration of real-world data in biomarker research, and the exploration of microbiome-based biomarkers.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Biomarkers Market?

The escalation in heart-related illnesses in the future is predicted to spur the development of the biomarkers market. The adoption of biomarkers for heart patients has witnessed a significant rise in recent years. At present, natriuretic peptides, a type of biomarker, find extensive use and aid in diagnosing heart failure. Circulating biomarkers exhibiting high sensitivity C-reactive protein are employed for heart failure diagnosis. Heart disease stands as a major reason behind mortality among diverse racial and ethnic groups in the United States. The surge in heart diseases will subsequently enhance the demand for biomarkers. As revealed by a report released by the American College of Cardiology, US-based non-profit medical association, in August 2022, there is an expected rise across all four cardiovascular risk factors in America between 2025 and 2060. Diabetes is anticipated to witness the highest percentage surge, with a projected 39.3% increase, affecting up to 55 million individuals. This is followed by dyslipidemia (27.6% impacting 126 million), hypertension (25.1% affecting 162 million), and obesity (18.3% affecting 126 million). The study further noted that the most significant predicted rises in cardiovascular disease rates were stroke (33.8% affecting 15 million) and heart failure (33.4% affecting 13 million), followed by ischemic heart disease (30. 7% affecting 29 million) and heart attack (16.9% affecting 16 million). Owing to the surge in heart diseases and associated mortalities, biomarkers will see an upswing in growth.

Which Primary Segments of the Biomarkers Market Are Driving Growth and Industry Transformations?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Biomarkers Market?# Market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Biomarkers Market?

Key players in the biomarker industry are concentrating on creating cutting-edge solutions like innovative biological markers to foster innovation via joint scientific research, incorporation of technology, and extensive clinical validation. A newly recognized sign that mirrors biological activities, the innovative biological marker aids in disease diagnosis or tracking. It could be a molecule, gene, or cellular attribute with potential benefits for individualized medicine. For example, in September 2024, Genialis, a leading American computational precision medicine company, introduced a pioneering biomarker. This first-of-its-kind biomarker improves forecasting accuracy for patient responses to KRAS inhibitors, allowing for tailored treatment strategies and better clinical outcomes. Furthermore, its wide applicability across various cancer forms enhances efficient drug creation and refines patient selection for target-specific therapies.

View the full report here:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Parameters Are Used to Define the Biomarkers Market?

Biomarkers refer to a biological molecule that is a marker for a condition, disease, or aberrant process and can be discovered in tissues, body fluids, or blood. It is used to determine how well the body responds to a disease or condition’s treatment. These biomarkers have a clinical role in narrowing or guiding treatment decisions.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Biomarkers Market?

The surge in instances of heart diseases is predicted to boost the progression of the biomarkers market throughout the forecast period. The employment of biomarkers for patients suffering from cardiac issues has risen exponentially in the recent past. As of now, natriuretic peptides are the most utilized biomarker, aiding in diagnosing heart failure patients. High-sensitivity C-reactive protein and other circulating biomarkers are deployed for identifying heart failure. Among various races and ethnic groups in the USA, heart disease is counted as the leading cause of demise. This escalation in heart disease instances will fuel the need for biomarkers. For example, a report issued by the American College of Cardiology, a US-based non-profitable medical institution, in August 2022, predicts that all four cardiovascular risk factors will witness a rise from 2025 to 2060 in the United States. According to the report, diabetes is expected to have the largest percentage upturn of 39.3%, amounting to 55 million people, followed by dyslipidemia (27.6% reaching 126 million), hypertension (25.1% escalating to 162 million), and obesity (18.3% amounting to 126 million). It was also observed by the researchers that the maximum projected increments in cardiovascular disease rates were in the case of stroke (33.8% reaching 15 million) and heart failure (33.4% touching 13 million), followed by ischemic heart disease (30.7% rising to 29 million) and heart attack (16.9% resulting in 16 million). Due to the surge in heart diseases and related deaths, an upward trend for the growth of the biomarkers is projected.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

#What is the Growth Potential of the Biomarkers Market, and How Will It Perform by 2034?

In recent years, the size of the biomarkers market has seen significant growth. It is expected to expand from a size of $68.77 billion in 2024 to reach $78.14 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. Factors contributing to this growth during the historical period include betterments in genomics and proteomics technologies, a rise in the occurrence of chronic diseases, a heightened focus on personalized medicine, an increased need for companion diagnostics, and a broadening of applications within drug development.

The size of the biomarkers market is predicted to show a swift expansion in the upcoming years, growing to a staggering $135.14 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%. The surge in this period is due to the increasing emphasis on early prevention and detection of diseases, the broadening scope of biomarkers in oncology and immunotherapy, mounting investment in precision medicine, the rise of liquid biopsy as a non-invasive method to detect biomarkers, and the growing use of biomarkers in drug discovery and development. Predicted trends in this forecast period encompass the advancement of multi-biomarker panels, the emergence of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the incorporation of real-world data into biomarker research, and the investigation into microbiome-based biomarkers.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

What Are the Most Significant Market Trends Transforming theBiomarkers Market?

Leading corporations in the biomarker sector are working to create innovative solutions, such as a groundbreaking biological marker. Their focus is on fostering innovation via collaborative research, integrating technology, and delivering strong clinical validation. A groundbreaking biological marker represents a newly discovered criterion that mirrors biological activities and aids in the detection or tracking of diseases. It could be a molecule, gene, or cellular characteristic with potential importance in personalized medicine. In September 2024, a computational precision medicine company based in the US, Genialis, introduced a first-of-its-kind biomarker. This pioneering biomarker amplifies predictive precision for patients’ responses to KRAS inhibitors, thus facilitating personalized treatment schedules and enhancing clinical results. It also bolsters efficient drug development and streamlines patient selection for targeted treatments due to its wide application across various cancer types.

What Are the Top Market Players Propelling the Growth of theBiomarkers Industry?

Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Which Primary Segments of the Biomarkers Market Are Driving Growth and Industry Transformations?

The biomarkers market covered in this report is segmented –

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Biomarkers Market?# Market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Biomarkers Maret 2025, By The Business Research Company:

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/biologics-market

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Dermatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the biomarkers market?

There has been a swift expansion in the biomarkers market size in the past few years. It is projected to rise from $68.77 billion in 2024 to $78.14 billion in 2025, marking a compound annual growth rate (CAGR) of 13.6%. The growth during the historic period is linked to developments in the field of genomics and proteomics, a rise in the occurrence of chronic diseases, heightened focus on personalized medicine, increased necessity for companion diagnostics, and broadening applications in drug development.

What will be the biomarkers market size in the future?

In the forthcoming years, the biomarkers market is projected to experience a swift expansion, increasing to $135.14 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 14.7%. Factors such as increased emphasis on early disease detection and prevention, the proliferation of biomarkers in oncology and immunotherapy, growth in investments in precision medicine initiatives, the emergence of liquid biopsy as a non-invasive method of biomarker detection, and an increased preference for biomarkers in drug discovery and development all contribute to this predicted growth. Noteworthy trends for the forecast period encompass the development of multi-biomarker panels, the surge of exosome-based biomarkers, the acceptance of point-of-care biomarker testing, the incorporation of real-world data in biomarker research, and the discovery of microbiome-based biomarkers.

Get your biomarkers market report here!

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What main drivers are fueling expansion in the biomarkers market?

In the forthcoming years, the biomarkers market is projected to experience a swift expansion, increasing to $135.14 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 14.7%. Factors such as increased emphasis on early disease detection and prevention, the proliferation of biomarkers in oncology and immunotherapy, growth in investments in precision medicine initiatives, the emergence of liquid biopsy as a non-invasive method of biomarker detection, and an increased preference for biomarkers in drug discovery and development all contribute to this predicted growth. Noteworthy trends for the forecast period encompass the development of multi-biomarker panels, the surge of exosome-based biomarkers, the acceptance of point-of-care biomarker testing, the incorporation of real-world data in biomarker research, and the discovery of microbiome-based biomarkers.

What key areas define the segmentation of the global biomarkers market?

The biomarkers market covered in this report is segmented – _x000D_

_x000D_

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers_x000D_

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases_x000D_

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases_x000D_

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies_x000D_

_x000D_

Subsegments:_x000D_

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers _x000D_

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers_x000D_

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers_x000D_

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

Who are the dominant players expanding their reach in the biomarkers market?

Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

How are evolving market trends shaping biomarkers Strategies?

Prominent businesses in the biomarker market are concentrating on creating innovative solutions such as a cutting-edge biological marker. They aim to foster innovation through cooperative research, the merging of technologies, and strong clinical validation. A new biological marker is a freshly discovered indicator, representing biological processes and assisting in disease detection or monitoring. This could be a molecule, a gene, or a cellular feature with potential use in individualized medicine. For example, Genialis, a computational precision medicine enterprise based in the US, introduced first-in-class biomarker in September 2024. This biomarker improves predictive accuracy for patient responses to KRAS inhibitors, facilitating customized treatment plans and enhancing clinical outcomes. It’s vast usability across different types of cancer promotes efficient pharmaceutical development and optimizes patient selection for targeted treatments.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

Which regions are emerging as leaders in the biomarkers market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/biologics-market

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Dermatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Rate is the Biomarkers Market Anticipated to Experience from 2025-2034?

In recent times, the biomarkers market has seen significant growth. The market value is projected to increase from $68.77 billion in 2024 to $78.14 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. The surge in growth during the historical period can be attributed to factors such as the progression of genomics and proteomics technologies, a higher incidence of chronic diseases, a growing focus on personalized medicine, an increased need for companion diagnostics, and the broadening of applications in drug development.

In the coming years, the biomarkers market size is set for fast-paced expansion. It is slated to grow to $135.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The factors driving the growth during the forecast period include increasing emphasis on early disease detection and prevention, widening usage of biomarkers in oncology and immunotherapy, escalating investment in precision medicine initiatives, popularity of liquid biopsy as a non-invasive method for biomarker detection, and a growing preference for biomarkers in the field of drug discovery and development. Key trends forecasted for the period encompass the development of multi-biomarker panels, the rise of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the integration of real-world data into biomarker research, and the exploration of microbiome-based biomarkers.

Claim Your Free Sample of the Global Biomarkers Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

What Are the Major Factors Contributing to the biomarkers Market Expansion?

The rise in cardiac conditions is anticipated to fuel the expansion of the biomarkers market during the projected period. The application of biomarkers in treating heart disease patients has vastly grown in recent years. Presently, biomarkers like natriuretic peptides, being most favored, are used to diagnose patients suffering from heart failure. Cardiac ailments are one of the prime causes of mortality across various racial and ethnic groups in the US, thereby driving the demand for biomarkers. For instance, a report published by the American College of Cardiology, a US-based medical non-profit organization in August 2022, predicted that all four cardiovascular risk factors are projected to elevate between 2025 and 2060. Diabetes is expected to see the highest percentage growth of 39.3%, amounting to 55 million individuals, followed by dyslipidemia (27.6% equating to 126 million), hypertension (25.1% coming to 162 million), and obesity (18.3% totaling 126 million). The examination also pointed out considerable projected increases in stroke rates (33.8% equalling 15 million) and heart failures (33.4% amounting to 13 million), after which is ischemic heart disease (30.7% equally 29 million) and heart attack (16.9% coming to 16 million). Due to the surge in heart ailments and resultant deaths, the biomarkers market is set for significant growth.

Which Key Segments Shape the Biomarkers Market?

The biomarkers market covered in this report is segmented – _x000D_

_x000D_

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers_x000D_

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases_x000D_

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases_x000D_

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies_x000D_

_x000D_

Subsegments:_x000D_

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers _x000D_

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers_x000D_

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers_x000D_

What Are the Transformative Trends Influencing the Biomarkers Market?

Leading firms in the biomarker market are concentrating their efforts on the creation of novel solutions such as innovative biological markers. This is achieved through a combination of partnership research, technology amalgamation, and rigorous clinical verification. A novel biological marker refers to a newly discovered sign that indicates biological changes, useful in disease diagnosis or supervision. It could be a certain molecule, gene, or cellular attribute, holding significant potential for personalized medicine. For instance, in September 2024, Genialis, an American company specializing in computational precision medicine, premiered a first-in-class biomarker. This biomarker manages to increase the predictive accuracy of patient responses to KRAS inhibitors. This facilitates individualized treatment plans and betters clinical results, with its far-reaching application across various cancer species furthering efficient drug creation and fine-tuning patient selection for specialized therapies.

Order Now for Fast Delivery of Your Biomarkers Market Report!

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Regions Are Leading the Growth Trajectory of the Biomarkers Market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Biomarkers Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biomarkers market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Biomarkers Market Include

1. Biomarkers Market Executive Summary

2. Biomarkers Market Segments

3. Biomarkers Market Size And Template Market Growth Rate

4. Key Biomarkers Market Trends

5. Major Biomarkers Market Drivers

……

25. Key Mergers And Acquisitions In The Biomarkers Market

26. Top Biomarkers Companies

27. Biomarkers Market Opportunities And Strategies

28. Biomarkers Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/biologics-market

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Dermatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Rate is the Biomarkers Market Anticipated to Experience from 2025-2034?

In recent times, the biomarkers market has seen significant growth. The market value is projected to increase from $68.77 billion in 2024 to $78.14 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. The surge in growth during the historical period can be attributed to factors such as the progression of genomics and proteomics technologies, a higher incidence of chronic diseases, a growing focus on personalized medicine, an increased need for companion diagnostics, and the broadening of applications in drug development.

In the coming years, the biomarkers market size is set for fast-paced expansion. It is slated to grow to $135.14 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The factors driving the growth during the forecast period include increasing emphasis on early disease detection and prevention, widening usage of biomarkers in oncology and immunotherapy, escalating investment in precision medicine initiatives, popularity of liquid biopsy as a non-invasive method for biomarker detection, and a growing preference for biomarkers in the field of drug discovery and development. Key trends forecasted for the period encompass the development of multi-biomarker panels, the rise of exosome-based biomarkers, the adoption of point-of-care biomarker testing, the integration of real-world data into biomarker research, and the exploration of microbiome-based biomarkers.

Claim Your Free Sample of the Global Biomarkers Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

What Are the Major Factors Contributing to the biomarkers Market Expansion?

The rise in cardiac conditions is anticipated to fuel the expansion of the biomarkers market during the projected period. The application of biomarkers in treating heart disease patients has vastly grown in recent years. Presently, biomarkers like natriuretic peptides, being most favored, are used to diagnose patients suffering from heart failure. Cardiac ailments are one of the prime causes of mortality across various racial and ethnic groups in the US, thereby driving the demand for biomarkers. For instance, a report published by the American College of Cardiology, a US-based medical non-profit organization in August 2022, predicted that all four cardiovascular risk factors are projected to elevate between 2025 and 2060. Diabetes is expected to see the highest percentage growth of 39.3%, amounting to 55 million individuals, followed by dyslipidemia (27.6% equating to 126 million), hypertension (25.1% coming to 162 million), and obesity (18.3% totaling 126 million). The examination also pointed out considerable projected increases in stroke rates (33.8% equalling 15 million) and heart failures (33.4% amounting to 13 million), after which is ischemic heart disease (30.7% equally 29 million) and heart attack (16.9% coming to 16 million). Due to the surge in heart ailments and resultant deaths, the biomarkers market is set for significant growth.

Which Key Segments Shape the Biomarkers Market?

The biomarkers market covered in this report is segmented – _x000D_

_x000D_

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers_x000D_

2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases_x000D_

3) By Type: Biomarker Of Exposure, Biomarker Of Diseases_x000D_

4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies_x000D_

_x000D_

Subsegments:_x000D_

1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers _x000D_

2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers_x000D_

3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers_x000D_

What Are the Transformative Trends Influencing the Biomarkers Market?

Leading firms in the biomarker market are concentrating their efforts on the creation of novel solutions such as innovative biological markers. This is achieved through a combination of partnership research, technology amalgamation, and rigorous clinical verification. A novel biological marker refers to a newly discovered sign that indicates biological changes, useful in disease diagnosis or supervision. It could be a certain molecule, gene, or cellular attribute, holding significant potential for personalized medicine. For instance, in September 2024, Genialis, an American company specializing in computational precision medicine, premiered a first-in-class biomarker. This biomarker manages to increase the predictive accuracy of patient responses to KRAS inhibitors. This facilitates individualized treatment plans and betters clinical results, with its far-reaching application across various cancer species furthering efficient drug creation and fine-tuning patient selection for specialized therapies.

Order Now for Fast Delivery of Your Biomarkers Market Report!

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What Regions Are Leading the Growth Trajectory of the Biomarkers Market?

North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Biomarkers Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biomarkers market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Biomarkers Market Include

1. Biomarkers Market Executive Summary

2. Biomarkers Market Segments

3. Biomarkers Market Size And Template Market Growth Rate

4. Key Biomarkers Market Trends

5. Major Biomarkers Market Drivers

……

25. Key Mergers And Acquisitions In The Biomarkers Market

26. Top Biomarkers Companies

27. Biomarkers Market Opportunities And Strategies

28. Biomarkers Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Biologics Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/biologics-market

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Dermatitis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: